Theranostics 2017; 7(2):466-481. doi:10.7150/thno.17411 This issue Cite

Research Paper

Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics

Yongbo Yang1, Lijia Jing1, Xiaoda Li1, Li Lin1, Xiuli Yue2✉, Zhifei Dai3✉

1. School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China;
2. School of Municipal and Environmental Engineering, Harbin Institute of Technology, Harbin 150080, China;
3. Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100871, China.

Citation:
Yang Y, Jing L, Li X, Lin L, Yue X, Dai Z. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics. Theranostics 2017; 7(2):466-481. doi:10.7150/thno.17411. https://www.thno.org/v07p0466.htm
Other styles

File import instruction

Abstract

Graphic abstract

A multifunctional nanotheranostic agent was developed by conjugating both hyaluronic acid and bovine serum albumin coated CuInS2-ZnS quantum dots onto the surface of magnetic Prussian blue nanoparticles. The obtained nanoagent could serve as an efficient contrast agent to simultaneously enhance near infrared (NIR) fluorescence and magnetic resonance (MR) imaging greatly. The coexistence of magnetic core and CD44 ligand hyaluronic acid was found to largely improve the specific uptake of the nanoagent by CD44 overexpressed HeLa cells upon applying an external magnetic field. Both NIR fluorescence and MR imaging in vivo proved high accumulation of the nanoagent at tumor site due to its excellent CD44 receptor/magnetic dual targeting capability. After intravenous injection of the nanoagent and treatment of external magnetic field, the tumor in nude mice was efficiently ablated upon NIR laser irradiation and the tumor growth inhibition was more than 89.95%. Such nanotheranostic agent is of crucial importance for accurately identifying the size and location of the tumor before therapy, monitoring the photothermal treatment procedure in real-time during therapy, assessing the effectiveness after therapy.

Keywords: Photothermal therapy, Bimodal Imaging, Prussian blue nanoparticles, Fe3O4 nanoparticles, Quantum Dots, Tumor targeting.


Citation styles

APA
Yang, Y., Jing, L., Li, X., Lin, L., Yue, X., Dai, Z. (2017). Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics. Theranostics, 7(2), 466-481. https://doi.org/10.7150/thno.17411.

ACS
Yang, Y.; Jing, L.; Li, X.; Lin, L.; Yue, X.; Dai, Z. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics. Theranostics 2017, 7 (2), 466-481. DOI: 10.7150/thno.17411.

NLM
Yang Y, Jing L, Li X, Lin L, Yue X, Dai Z. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics. Theranostics 2017; 7(2):466-481. doi:10.7150/thno.17411. https://www.thno.org/v07p0466.htm

CSE
Yang Y, Jing L, Li X, Lin L, Yue X, Dai Z. 2017. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics. Theranostics. 7(2):466-481.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image